Bioforce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 05, 2019 at 09:03 pm
Share
BioForce Nanosciences Holdings, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was USD 5,962 compared to USD 5,512 a year ago. Operating loss was USD 6,334 compared to USD 6,643 a year ago. Net loss was USD 6,334 compared to USD 6,643 a year ago. For the nine months, sales was USD 17,775 compared to USD 10,575 a year ago. Operating loss was USD 26,368 compared to USD 58,146 a year ago. Net loss was USD 26,368 compared to USD 59,144 a year ago.
BioForce Nanosciences Holdings, Inc. is a provider of natural vitamins, minerals and other nutritional supplements, powders and beverages, formulated to promote a healthier lifestyle for active individuals in all age ranges. The Company markets its products through social media and telemarketing. The Company seeks to expand its BioForce Eclipse nutritional powder for use into households throughout the United States. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, focuses to be the channels for the Companyâs Eclipse product lines. The Company private labels the powder through a manufacturer located in Virginia. The Company caters to the needs of customers with a focus on the elderly and athletes across numerous sports, ages, and economic backgrounds. The Company also focuses on offering its products for direct sales on its Website at www.bioforceeclipse.com. The Companyâs wholly owned subsidiary is Element Global, Inc.
BIOFORCE NANOSCIENCES HOLDINGS, INC. 
